IE 11 is a very old Browser and it`s not supported on this site
de en
Interim report as at 30.06.2024
de en
Business reportPerformance / Multi-year comparison
Business Report Performance

Performance/Multi-year comparison

Indexed performance since launch

BB Biotech AG (SIX)-CHF
BB BIOTECH AG (XETRA)-EUR
BB Biotech AG (SIX)-CHF
BB BIOTECH AG (XETRA)-EUR

Created with Highcharts 8.2.0In %Chart title199419961998200020022004200620082010201220142016201820202022202405001000150020002500300035004000

NAV CHF indexed
Share Price CHF indexed
Nasdaq Biotech Index (NBI) TR indexed

Rolling performance

XLS

SHARE

NAV

NBI TR

30.06.2023 – 30.06.2024

7.2%

10.2%

12.9%

30.06.2022 – 30.06.2023

(27.1%)

(3.5%)

2.8%

30.06.2021 – 30.06.2022

(31.2%)

(32.4%)

(24.3%)

30.06.2020 – 30.06.2021

30.9%

17.0%

17.8%

28.06.2019 – 30.06.2020

11.7%

20.1%

22.3%

Annual performance

XLS

SHARE

NAV

NBI TR

2023

(18.1%)

(7.4%)

(4.8%)

2022

(24.3%)

(11.0%)

(9.1%)

2021

8.3%

(11.5%)

3.0%

2020

19.3%

24.3%

15.8%

2019

18.5%

23.4%

23.0%

Cumulated performance

30.06.2024

XLS

SHARE

NAV

NBI TR

YTD

(2.0%)

7.3%

11.9%

1 year

7.2%

10.2%

12.9%

3 years

(46.2%)

(28.1%)

(12.1%)

5 years

(21.3%)

1.0%

26.5%

10 years

109%

86.4%

81.6%

since inception 1)

1 839%

2 002%

1 349%

1 09.11.1993

Annualized performance

30.06.2024

XLS

SHARE

NAV

NBI TR

1 year

7.2%

10.2%

12.9%

3 years

(18.7%)

(10.4%)

(4.2%)

5 years

(4.7%)

0.2%

4.8%

10 years

7.6%

6.4%

6.1%

since inception 1)

10.2%

10.5%

9.1%

1 09.11.1993

Created with Highcharts 8.2.0In %Chart title199820002002200420062008201020122014201620182020202220240500100015002000250030003500

NAV EUR indexed
Share Price EUR indexed
Nasdaq Biotech Index (NBI) TR indexed

Rolling performance

XLS

SHARE

NAV

NBI TR

30.06.2023 – 30.06.2024

8.6%

11.9%

14.5%

30.06.2022 – 30.06.2023

(25.9%)

(1.2%)

5.2%

30.06.2021 – 30.06.2022

(23.9%)

(25.9%)

(17.0%)

30.06.2020 – 30.06.2021

26.5%

13.5%

14.4%

28.06.2019 – 30.06.2020

17.0%

25.3%

27.4%

Annual performance

XLS

SHARE

NAV

NBI TR

2023

(15.2%)

(1.3%)

1.3%

2022

(19.0%)

(6.7%)

(4.5%)

2021

13.3%

(7.8%)

7.4%

2020

18.1%

24.8%

16.1%

2019

23.4%

28.1%

27.6%

Cumulated performance

30.06.2024

XLS

SHARE

NAV

NBI TR

YTD

(4.6%)

3.5%

7.9%

1 year

8.6%

11.9%

14.5%

3 years

(38.7%)

(18.0%)

0.1%

5 years

(9.3%)

16.5%

45.8%

10 years

162%

135%

129%

since inception 1)

1 641%

1 796%

1 482%

1 10.12.1997

Annualized performance

30.06.2024

XLS

SHARE

NAV

NBI TR

1 year

8.6%

11.9%

14.5%

3 years

(15.1%)

(6.4%)

0.0%

5 years

(1.9%)

3.1%

7.8%

10 years

10.1%

8.9%

8.6%

since inception 1)

11.3%

11.7%

10.9%

1 10.12.1997

Multi-year comparison

XLS

30.06.2024

2023

2022

2021

2020

Market capitalization at the end of the period (in CHF mn)

2 221.5

2 368.4

3 058.1

4 274.1

4 107.9

toggle chart

Net Asset Value at the end of the period (in CHF mn)

2 386.9

2 323.2

2 686.1

3 283.5

3 887.5

toggle chart

Number of shares (in mn)

55.4

55.4

55.4

55.4

55.4

toggle chart

Trading volume (in CHF mn)

501.6

906.3

1 482.0

2 101.0

2 315.6

toggle chart

Profit/(loss) (in CHF mn)

173.4

(206.6)

(357.8)

(404.8)

691.2

toggle chart

Closing price at the end of the period in CHF

40.10

42.75

55.20

77.15

74.15

toggle chart

Closing price at the end of the period in EUR

41.60

45.50

56.70

74.05

68.00

toggle chart

Stock performance (incl. distributions) 1)

(2.0%)

(18.1%)

(24.3%)

8.3%

19.3%

toggle chart

High/low share price in CHF

49.35/38.70

60.70/35.60

78.15/51.00

92.20/73.40

74.70/45.44

toggle chart

High/low share price in EUR

52.00/40.15

60.50/37.10

75.40/49.60

86.20/67.80

69.00/43.04

toggle chart

Premium/(discount) (annual average)

(1.2%)

7.5%

20.5%

19.5%

9.2%

toggle chart

Dividend in CHF

N.A.

2.00

2.85

3.85

3.60

toggle chart

Degree of investment (quarterly figures)

113.8%

113.7%

112.8%

108.6%

106.8%

toggle chart

Total Expense Ratio (TER) p.a. 2)

1.35%

1.34%

1.27%

1.22%

1.25%

toggle chart

1All figures in CHF %, total return-methodology

2Based on market capitalization